- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | 120 | 0.0 | 0.0 | 1.52 | 260.0 | -43.91 | 2.08 | 87.39 | 116.67 | 1.05 | 323.4 | -69.12 | 12.12 | 7.35 | 13.48 | 43.38 | 0.6 | 3.71 | 2.35 | 58.78 | 123.81 | 1.83 | 259.13 | -43.87 | 13.85 | 256.67 | -53.11 | 10.18 | 169.54 | -60.11 | 5.60 | 11.16 | 40.73 |
| 23Q3 (19) | 120 | 0.0 | 0.0 | -0.95 | -237.68 | -123.23 | 1.11 | -5.93 | 29.07 | -0.47 | -197.92 | -168.12 | 11.29 | 3.86 | 10.25 | 43.12 | -6.0 | 11.31 | 1.48 | -6.33 | 43.69 | -1.15 | -238.55 | -123.37 | -8.84 | -196.3 | -118.41 | -14.64 | -373.13 | -133.46 | 10.24 | 95.44 | -0.28 |
| 23Q2 (18) | 120 | 0.0 | 0.0 | 0.69 | 428.57 | 1085.71 | 1.18 | 5.36 | 413.04 | 0.48 | 328.57 | 114.12 | 10.87 | 16.63 | 29.71 | 45.87 | 3.8 | 32.04 | 1.58 | 17.91 | 2533.33 | 0.83 | 432.0 | 1022.22 | 9.18 | 433.82 | 348.78 | 5.36 | 172.83 | 190.39 | 1.95 | 160.41 | 11.02 |
| 23Q1 (17) | 120 | 0.0 | 0.0 | -0.21 | -107.75 | 93.69 | 1.12 | 16.67 | 1966.67 | -0.21 | -106.18 | 93.69 | 9.32 | -12.73 | 11.62 | 44.19 | 5.64 | 44.51 | 1.34 | 27.62 | 362.75 | -0.25 | -107.67 | 93.75 | -2.75 | -109.31 | 94.82 | -7.36 | -128.84 | 86.47 | -4.21 | -70.75 | 14.15 |
| 22Q4 (16) | 120 | 0.0 | 5.26 | 2.71 | -33.74 | 274.84 | 0.96 | 11.63 | 123.26 | 3.40 | 392.75 | -68.86 | 10.68 | 4.3 | 20.13 | 41.83 | 7.98 | 40.56 | 1.05 | 1.94 | 1212.5 | 3.26 | -33.74 | 284.18 | 29.54 | -38.48 | 218.49 | 25.52 | -41.68 | 192.26 | 13.25 | 2954.56 | 142.77 |
| 22Q3 (15) | 120 | 0.0 | 0.0 | 4.09 | 5942.86 | 227.81 | 0.86 | 273.91 | 960.0 | 0.69 | 120.29 | -94.56 | 10.24 | 22.2 | 48.41 | 38.74 | 11.51 | 21.48 | 1.03 | 1616.67 | 306.0 | 4.92 | 5566.67 | 227.79 | 48.02 | 1401.36 | 178.44 | 43.76 | 837.94 | 169.36 | 11.28 | 3020.38 | 378.62 |
| 22Q2 (14) | 120 | 0.0 | 10.09 | -0.07 | 97.9 | -101.02 | 0.23 | 483.33 | 866.67 | -3.40 | -2.1 | -120.36 | 8.38 | 0.36 | 1.33 | 34.74 | 13.6 | 8.36 | 0.06 | 111.76 | 110.53 | -0.09 | 97.75 | -101.21 | -3.69 | 93.05 | -104.42 | -5.93 | 89.1 | -107.12 | -2.85 | -8.47 | 184.69 |
| 22Q1 (13) | 120 | 5.26 | 11.11 | -3.33 | -114.84 | -133.84 | -0.06 | -113.95 | 83.33 | -3.33 | -130.49 | -133.84 | 8.35 | -6.07 | 13.45 | 30.58 | 2.76 | 1.59 | -0.51 | -737.5 | 26.09 | -4.0 | -125.99 | -137.52 | -53.08 | -112.92 | -137.58 | -54.41 | -96.71 | -138.7 | 11.38 | -31.64 | 208.03 |
| 21Q4 (12) | 114 | -5.0 | 7.55 | -1.55 | 51.56 | -23.02 | 0.43 | 530.0 | -44.16 | 10.92 | -13.95 | 188.89 | 8.89 | 28.84 | 9.75 | 29.76 | -6.68 | -6.8 | 0.08 | 116.0 | -92.45 | -1.77 | 54.03 | -33.08 | -24.93 | 59.28 | -70.64 | -27.66 | 56.16 | -54.53 | 6.13 | -47.55 | 148.33 |
| 21Q3 (11) | 120 | 10.09 | 11.11 | -3.20 | -146.65 | -444.09 | -0.10 | -233.33 | -147.62 | 12.69 | -24.01 | 149.31 | 6.9 | -16.57 | -15.34 | 31.89 | -0.53 | 4.28 | -0.5 | 12.28 | -363.16 | -3.85 | -151.68 | -481.19 | -61.22 | -173.26 | -625.04 | -63.09 | -175.72 | -738.56 | -2.11 | -88.47 | -70.83 |
| 21Q2 (10) | 109 | 0.93 | 1.87 | 6.86 | -30.28 | 37.47 | -0.03 | 91.67 | 76.92 | 16.70 | 69.72 | 297.62 | 8.27 | 12.36 | 4.95 | 32.06 | 6.51 | 1.39 | -0.57 | 17.39 | -16.33 | 7.45 | -30.11 | 39.51 | 83.57 | -40.84 | 31.36 | 83.32 | -40.74 | 27.6 | 1.61 | 425.34 | -27.54 |
| 21Q1 (9) | 108 | 1.89 | 9.09 | 9.84 | 880.95 | 1055.34 | -0.36 | -146.75 | -28.57 | 9.84 | 160.32 | 1055.34 | 7.36 | -9.14 | 11.01 | 30.10 | -5.73 | 5.99 | -0.69 | -165.09 | -43.75 | 10.66 | 901.5 | 1145.1 | 141.25 | 1066.8 | 902.56 | 140.61 | 885.53 | 872.16 | -4.88 | 322.74 | 59.96 |
| 20Q4 (8) | 106 | -1.85 | 7.07 | -1.26 | -235.48 | -70.27 | 0.77 | 266.67 | 10.0 | 3.78 | -25.74 | 3050.0 | 8.1 | -0.61 | 12.19 | 31.93 | 4.41 | 4.86 | 1.06 | 457.89 | 146.51 | -1.33 | -231.68 | -82.19 | -14.61 | -225.3 | 7.3 | -17.90 | -281.17 | -55.52 | 1.41 | -158.42 | 264.11 |
| 20Q3 (7) | 108 | 0.93 | 9.09 | 0.93 | -81.36 | -46.55 | 0.21 | 261.54 | -70.0 | 5.09 | 21.19 | 491.86 | 8.15 | 3.43 | 3.16 | 30.58 | -3.29 | -16.4 | 0.19 | 138.78 | -80.81 | 1.01 | -81.09 | -41.28 | 11.66 | -81.67 | -50.76 | 9.88 | -84.87 | -51.83 | 11.14 | 251.56 | 157.56 |
| 20Q2 (6) | 107 | 8.08 | 8.08 | 4.99 | 584.47 | 515.83 | -0.13 | 53.57 | 27.78 | 4.20 | 507.77 | 577.27 | 7.88 | 18.85 | 32.66 | 31.62 | 11.34 | 6.25 | -0.49 | -2.08 | -133.33 | 5.34 | 623.53 | 548.74 | 63.62 | 461.48 | 421.15 | 65.30 | 458.59 | 389.19 | 5.34 | 272.64 | -43.22 |
| 20Q1 (5) | 99 | 0.0 | 0.0 | -1.03 | -39.19 | -421.88 | -0.28 | -140.0 | 50.88 | -1.03 | -958.33 | -421.88 | 6.63 | -8.17 | 1.38 | 28.40 | -6.73 | 32.77 | -0.48 | -211.63 | 50.52 | -1.02 | -39.73 | -418.75 | -17.60 | -11.68 | -2807.69 | -18.21 | -58.21 | -943.06 | - | - | 0.00 |
| 19Q4 (4) | 99 | 0.0 | 0.0 | -0.74 | -142.53 | 0.0 | 0.70 | 0.0 | 0.0 | 0.12 | -86.05 | 0.0 | 7.22 | -8.61 | 0.0 | 30.45 | -16.76 | 0.0 | 0.43 | -56.57 | 0.0 | -0.73 | -142.44 | 0.0 | -15.76 | -166.55 | 0.0 | -11.51 | -156.12 | 0.0 | - | - | 0.00 |
| 19Q3 (3) | 99 | 0.0 | 0.0 | 1.74 | 245.0 | 0.0 | 0.70 | 488.89 | 0.0 | 0.86 | 197.73 | 0.0 | 7.9 | 33.0 | 0.0 | 36.58 | 22.92 | 0.0 | 0.99 | 571.43 | 0.0 | 1.72 | 244.54 | 0.0 | 23.68 | 219.54 | 0.0 | 20.51 | 190.83 | 0.0 | - | - | 0.00 |
| 19Q2 (2) | 99 | 0.0 | 0.0 | -1.20 | -475.0 | 0.0 | -0.18 | 68.42 | 0.0 | -0.88 | -375.0 | 0.0 | 5.94 | -9.17 | 0.0 | 29.76 | 39.13 | 0.0 | -0.21 | 78.35 | 0.0 | -1.19 | -471.88 | 0.0 | -19.81 | -3147.69 | 0.0 | -22.58 | -1145.37 | 0.0 | - | - | 0.00 |
| 19Q1 (1) | 99 | 0.0 | 0.0 | 0.32 | 0.0 | 0.0 | -0.57 | 0.0 | 0.0 | 0.32 | 0.0 | 0.0 | 6.54 | 0.0 | 0.0 | 21.39 | 0.0 | 0.0 | -0.97 | 0.0 | 0.0 | 0.32 | 0.0 | 0.0 | 0.65 | 0.0 | 0.0 | 2.16 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 5.63 | 129.29 | 46.06 | 11.34 | 21.68 | 11.34 | N/A | 本月營收增加主係合併子公司台新藥認列Eyenovia授權金 | ||
| 2024/2 | 2.46 | -24.42 | -11.3 | 5.71 | 4.47 | 10.65 | N/A | - | ||
| 2024/1 | 3.25 | -34.24 | 20.7 | 3.25 | 20.7 | 11.35 | N/A | - | ||
| 2023/12 | 4.94 | 56.76 | 32.4 | 43.6 | 15.79 | 12.12 | 1.32 | - | ||
| 2023/11 | 3.15 | -21.66 | -7.72 | 38.66 | 13.97 | 11.03 | 1.45 | - | ||
| 2023/10 | 4.03 | 4.5 | 13.99 | 35.51 | 16.4 | 11.89 | 1.34 | - | ||
| 2023/9 | 3.85 | -4.02 | -4.83 | 31.48 | 16.71 | 11.29 | 1.47 | - | ||
| 2023/8 | 4.01 | 17.15 | 43.84 | 27.63 | 20.52 | 11.89 | 1.4 | - | ||
| 2023/7 | 3.43 | -22.98 | 0.71 | 23.62 | 17.29 | 11.17 | 1.48 | - | ||
| 2023/6 | 4.45 | 34.85 | 43.34 | 20.19 | 20.66 | 10.87 | 1.6 | - | ||
| 2023/5 | 3.3 | 5.67 | 37.74 | 15.74 | 15.49 | 10.28 | 1.69 | - | ||
| 2023/4 | 3.12 | -19.05 | 8.24 | 12.44 | 10.75 | 9.75 | 1.78 | - | ||
| 2023/3 | 3.86 | 39.23 | 12.66 | 9.32 | 11.62 | 9.32 | 1.73 | - | ||
| 2023/2 | 2.77 | 2.84 | 34.08 | 5.46 | 10.89 | 9.2 | 1.75 | - | ||
| 2023/1 | 2.69 | -27.86 | -5.84 | 2.69 | -5.84 | 9.84 | 1.64 | - | ||
| 2022/12 | 3.73 | 9.24 | 16.2 | 37.66 | 19.82 | 10.68 | 1.5 | - | ||
| 2022/11 | 3.42 | -3.22 | 9.91 | 33.92 | 20.24 | 11.0 | 1.46 | - | ||
| 2022/10 | 3.53 | -12.75 | 37.48 | 30.5 | 21.52 | 10.37 | 1.54 | - | ||
| 2022/9 | 4.05 | 45.06 | 44.8 | 26.97 | 19.7 | 10.24 | 1.52 | - | ||
| 2022/8 | 2.79 | -17.96 | 31.03 | 22.92 | 16.14 | 9.3 | 1.68 | - | ||
| 2022/7 | 3.4 | 9.61 | 77.51 | 20.13 | 14.34 | 8.9 | 1.75 | 本月較同期增加主係膽固醇磷酸鹽結合劑歐洲客戶訂單增加及呼吸系統用藥接獲來自大陸客戶訂單所致。 | ||
| 2022/6 | 3.1 | 29.58 | 8.33 | 16.73 | 6.62 | 8.38 | 1.97 | - | ||
| 2022/5 | 2.39 | -16.95 | -4.78 | 13.63 | 6.24 | 8.7 | 1.89 | - | ||
| 2022/4 | 2.88 | -15.75 | -2.2 | 11.23 | 8.93 | 8.37 | 1.97 | - | ||
| 2022/3 | 3.42 | 65.71 | 35.0 | 8.35 | 13.4 | 8.35 | 1.92 | - | ||
| 2022/2 | 2.07 | -27.78 | -15.15 | 4.93 | 2.05 | 8.14 | 1.97 | - | ||
| 2022/1 | 2.86 | -10.97 | 19.57 | 2.86 | 19.57 | 9.18 | 1.74 | - | ||
| 2021/12 | 3.21 | 3.33 | -3.56 | 31.42 | 2.17 | 8.89 | 1.84 | - | ||
| 2021/11 | 3.11 | 21.04 | 49.73 | 28.21 | 2.87 | 8.47 | 1.93 | - | ||
| 2021/10 | 2.57 | -8.11 | -4.7 | 25.1 | -0.96 | 7.49 | 2.19 | - | ||
| 2021/9 | 2.8 | 31.27 | -0.38 | 22.53 | -0.51 | 6.84 | 2.33 | - | ||
| 2021/8 | 2.13 | 11.13 | -27.24 | 19.74 | -0.53 | 6.91 | 2.31 | - | ||
| 2021/7 | 1.92 | -33.1 | -20.62 | 17.61 | 4.07 | 7.3 | 2.19 | - | ||
| 2021/6 | 2.86 | 13.89 | 2.72 | 15.69 | 8.19 | 8.33 | 1.87 | - | ||
| 2021/5 | 2.52 | -14.7 | -3.24 | 12.83 | 9.49 | 8.0 | 1.95 | - | ||
| 2021/4 | 2.95 | 16.29 | 18.48 | 10.31 | 13.12 | 7.92 | 1.97 | - | ||
| 2021/3 | 2.54 | 4.13 | -12.24 | 7.36 | 11.11 | 7.36 | 2.06 | - | ||
| 2021/2 | 2.43 | 1.78 | 25.13 | 4.83 | 29.17 | 8.16 | 1.86 | - | ||
| 2021/1 | 2.39 | -28.2 | 33.56 | 2.39 | 33.56 | 7.8 | 1.94 | - | ||
| 2020/12 | 3.33 | 60.45 | 15.96 | 30.75 | 11.55 | 8.1 | 1.79 | - | ||
| 2020/11 | 2.08 | -22.96 | -3.57 | 27.42 | 11.04 | 7.58 | 1.91 | - | ||
| 2020/10 | 2.7 | -3.94 | 23.08 | 25.35 | 12.44 | 8.43 | 1.72 | - | ||
| 2020/9 | 2.81 | -4.12 | 4.04 | 22.65 | 11.29 | 8.15 | 1.69 | - | ||
| 2020/8 | 2.93 | 21.24 | 18.36 | 19.84 | 12.4 | 8.13 | 1.7 | - | ||
| 2020/7 | 2.41 | -13.43 | -11.43 | 16.92 | 11.43 | 7.8 | 1.77 | - | ||
| 2020/6 | 2.79 | 7.26 | 54.54 | 14.5 | 16.44 | 7.88 | 1.79 | 本月營收增加主因係膽固醇磷酸鹽結合劑產品之印度客戶出貨增加所致。 | ||
| 2020/5 | 2.6 | 4.45 | 31.47 | 11.71 | 9.98 | 7.98 | 1.76 | - | ||
| 2020/4 | 2.49 | -13.87 | 15.29 | 9.12 | 5.08 | 7.32 | 1.92 | - | ||
| 2020/3 | 2.89 | 48.5 | 35.36 | 6.63 | 1.7 | 6.63 | 1.98 | - | ||
| 2020/2 | 1.95 | 8.63 | 3.35 | 3.74 | -14.69 | 6.61 | 1.99 | - | ||
| 2020/1 | 1.79 | -37.65 | -28.29 | 1.79 | -28.29 | 6.82 | 1.93 | - | ||
| 2019/12 | 2.87 | 33.41 | 19.09 | 27.57 | 2.46 | 7.22 | 1.73 | - | ||
| 2019/11 | 2.15 | -1.66 | -8.37 | 24.69 | 0.82 | 7.04 | 1.77 | - | ||
| 2019/10 | 2.19 | -18.8 | -2.08 | 22.54 | 1.8 | 7.36 | 1.69 | - | ||
| 2019/9 | 2.7 | 9.07 | 17.18 | 20.35 | 2.24 | 7.9 | 1.61 | - | ||
| 2019/8 | 2.47 | -9.28 | 7.44 | 17.65 | 0.28 | 7.0 | 1.82 | - | ||
| 2019/7 | 2.73 | 51.07 | 21.35 | 15.18 | -0.78 | 6.51 | 1.96 | - | ||
| 2019/6 | 1.8 | -8.74 | -31.42 | 12.46 | -4.59 | 5.94 | 2.12 | - | ||
| 2019/5 | 1.98 | -8.39 | -13.93 | 10.65 | 2.17 | 0.0 | N/A | - | ||
| 2019/4 | 2.16 | 1.12 | 7.88 | 8.67 | 6.72 | 0.0 | N/A | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 120 | 0.0 | 1.05 | -69.03 | 5.49 | 175.88 | 43.6 | 15.77 | 44.11 | 19.47 | 6.75 | 314.11 | 1.42 | -57.36 | 1.26 | -69.19 |
| 2022 (9) | 120 | 5.26 | 3.39 | -67.15 | 1.99 | 0 | 37.66 | 19.86 | 36.92 | 19.44 | 1.63 | 0 | 3.33 | -69.39 | 4.09 | -67.25 |
| 2021 (8) | 114 | 7.55 | 10.32 | 198.27 | -0.06 | 0 | 31.42 | 2.18 | 30.91 | 0.59 | -1.68 | 0 | 10.88 | 201.39 | 12.49 | 212.25 |
| 2020 (7) | 106 | 7.07 | 3.46 | 2783.33 | 0.56 | -12.5 | 30.75 | 11.41 | 30.73 | 2.74 | 0.28 | 16.67 | 3.61 | 0 | 4.0 | 3233.33 |
| 2019 (6) | 99 | 4.21 | 0.12 | -93.26 | 0.64 | -15.79 | 27.6 | 2.68 | 29.91 | -12.06 | 0.24 | -60.0 | -0.4 | 0 | 0.12 | -93.22 |
| 2018 (5) | 95 | 4.4 | 1.78 | -30.2 | 0.76 | -70.2 | 26.88 | 5.87 | 34.01 | -14.14 | 0.6 | -84.13 | 1.47 | -52.73 | 1.77 | -25.94 |
| 2017 (4) | 91 | 3.41 | 2.55 | -51.24 | 2.55 | -42.7 | 25.39 | -20.38 | 39.61 | 0.46 | 3.78 | -42.99 | 3.11 | -49.18 | 2.39 | -50.52 |
| 2016 (3) | 88 | 3.53 | 5.23 | 68.71 | 4.45 | 102.27 | 31.89 | 22.8 | 39.43 | 27.03 | 6.63 | 103.37 | 6.12 | 77.91 | 4.83 | 71.28 |
| 2015 (2) | 85 | 1.19 | 3.10 | 4.03 | 2.20 | 17.02 | 25.97 | 4.05 | 31.04 | 12.83 | 3.26 | 18.98 | 3.44 | 10.97 | 2.82 | 7.63 |
| 2014 (1) | 84 | 18.31 | 2.98 | 0 | 1.88 | 0 | 24.96 | 0.89 | 27.51 | 0 | 2.74 | 0 | 3.1 | 0 | 2.62 | 0 |
